External broker reports(aggregated public sources), ICICI Securities Ltd

ICICI Securities Limited

External broker reports(aggregated public sources)

ICICI Securities Ltd

ICICI Securities Limited provides investment services. The Company provides corporate and investment banking, securities, wealth management, retail brokerage, initial public offerings, and advisory services. 

Content available is external broker reports authored by a third party outside the Smartkarma network and has been aggregated by an online aggregator through publicly available sources and is displayed by Smartkarma in this format for user's convenience and general informational purposes only. Content does not constitute investment or financial advice and Smartkarma makes no representation or warranty regarding its accuracy or contents. Original third party author retains all copyright and other proprietary rights in the content. Access or use of third party links not controlled by Smartkarma are at the user's own risk.

Equity Bottom-Up

Apollo Hospitals Enterprise / Equity Bottom-Up

<ul><li>Apollo is one of the leading integrated healthcare service provider with avenues like hospitals, pharmacies, primary care &amp; diagnostic clinics</li><li>Apollo reported in line results but it was skewed with hospitals lagging our expectations while pharmacies were a beat on our estimates</li><li>Target Price and Valuation: We value Apollo at Rs 5480 based on SOTP valuation.</li></ul><div class="content-highlight"><em>Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.</em></div>

Apollo is one of the leading integrated healthcare service provider with avenues like hospitals, pharmacies, primary care &amp; diagnostic clinicsApollo reported in line results but it was skewed with hospitals lagging our expectations while pharmacies were a beat on our estimatesTarget Price and Valuation: We value Apollo at Rs 5480 based on SOTP valuation.Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.

Apollo Hospitals: In Line Quarter; Numbers Trend Pre-Covid Level

External broker reports(aggregated public sources), Geojit BNP Paribas

Geojit

<p>During Q1FY22, standalone revenue continued onto its growth trajectory rising 24.1% QoQ owing to higher sales achieved via its digital platform and partly aided by rising participation by the public in...</p><div class="content-highlight"><em>Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.</em></div>

During Q1FY22, standalone revenue continued onto its growth trajectory rising 24.1% QoQ owing to higher sales achieved via its digital platform and partly aided by rising participation by the public in...Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.

Apollo Hospital: Momentum Sustained; Valuations Expensive

India

Apollo Hospitals Enterprise Limited owns and operates hospitals in India.  The Company also runs a 24-hour pharmacy network via over 120 outlets across India. Apollo Hospitals also runs clinics and offer managed care and family health plans. The Company has a variety of locations in Chennai, Hyderabad, Delhi, Dubai, Vizag, Bilaspur and Chengannur.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Apollo Hospitals Enterprise (APHS IN)

Apollo Hospitals: In Line Quarter; Numbers Trend Pre-Covid Level

Apollo Health & Lifestyle runs the largest chain of standardised primary healthcare models, multi-specialty clinics under the brand: Apollo Clinics...

ICICI Securities Limited

Apollo Hospital: Momentum Sustained; Valuations Expensive

During Q1FY22, standalone revenue continued onto its growth trajectory rising 24.1% QoQ owing to higher sales achieved via its digital platform and...

Geojit

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)